Literature DB >> 31591255

Biomarkers to Predict Progression in IgA Nephropathy.

Chee Kay Cheung1,2, Jonathan Barratt3,2.   

Abstract

Entities:  

Keywords:  Glomerulonephritis, IGA; IgA nephropathy; biomarkers; complement; disease progression; glomerulonephritis; immune complexes; immunology; risk factors

Year:  2019        PMID： 31591255      PMCID： PMC6777594          DOI： 10.2215/CJN.09100819

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Moderator's view: Biomarkers in glomerular diseases--translated into patient care or lost in translation?

Authors:  Pierre Ronco
Journal:  Nephrol Dial Transplant       Date:  2015-06       Impact factor: 5.992

Review 2.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

Review 3.  Is immunoglobulin A nephropathy different in different ethnic populations?

Authors:  See Cheng Yeo; Su Mein Goh; Jonathan Barratt
Journal:  Nephrology (Carlton)       Date:  2019-05-01       Impact factor: 2.506

4.  Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.

Authors:  Sean J Barbour; Rosanna Coppo; Hong Zhang; Zhi-Hong Liu; Yusuke Suzuki; Keiichi Matsuzaki; Ritsuko Katafuchi; Lee Er; Gabriela Espino-Hernandez; S Joseph Kim; Heather N Reich; John Feehally; Daniel C Cattran
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

5.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Authors:  Horia C Stanescu; Mauricio Arcos-Burgos; Alan Medlar; Detlef Bockenhauer; Anna Kottgen; Liviu Dragomirescu; Catalin Voinescu; Naina Patel; Kerra Pearce; Mike Hubank; Henry A F Stephens; Valerie Laundy; Sandosh Padmanabhan; Anna Zawadzka; Julia M Hofstra; Marieke J H Coenen; Martin den Heijer; Lambertus A L M Kiemeney; Delphine Bacq-Daian; Benedicte Stengel; Stephen H Powis; Paul Brenchley; John Feehally; Andrew J Rees; Hanna Debiec; Jack F M Wetzels; Pierre Ronco; Peter W Mathieson; Robert Kleta
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

6.  The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression.

Authors:  Na Zhao; Ping Hou; Jicheng Lv; Zina Moldoveanu; Yifu Li; Krzysztof Kiryluk; Ali G Gharavi; Jan Novak; Hong Zhang
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

7.  A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.

Authors:  Hiroyuki Yanagawa; Hitoshi Suzuki; Yusuke Suzuki; Krzysztof Kiryluk; Ali G Gharavi; Kiyoshi Matsuoka; Yuko Makita; Bruce A Julian; Jan Novak; Yasuhiko Tomino
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

Review 8.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

9.  Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.

Authors:  Krzysztof Kiryluk; Yifu Li; Francesco Scolari; Simone Sanna-Cherchi; Murim Choi; Miguel Verbitsky; David Fasel; Sneh Lata; Sindhuri Prakash; Samantha Shapiro; Clara Fischman; Holly J Snyder; Gerald Appel; Claudia Izzi; Battista Fabio Viola; Nadia Dallera; Lucia Del Vecchio; Cristina Barlassina; Erika Salvi; Francesca Eleonora Bertinetto; Antonio Amoroso; Silvana Savoldi; Marcella Rocchietti; Alessandro Amore; Licia Peruzzi; Rosanna Coppo; Maurizio Salvadori; Pietro Ravani; Riccardo Magistroni; Gian Marco Ghiggeri; Gianluca Caridi; Monica Bodria; Francesca Lugani; Landino Allegri; Marco Delsante; Mariarosa Maiorana; Andrea Magnano; Giovanni Frasca; Emanuela Boer; Giuliano Boscutti; Claudio Ponticelli; Renzo Mignani; Carmelita Marcantoni; Domenico Di Landro; Domenico Santoro; Antonello Pani; Rosaria Polci; Sandro Feriozzi; Silvana Chicca; Marco Galliani; Maddalena Gigante; Loreto Gesualdo; Pasquale Zamboli; Giovanni Giorgio Battaglia; Maurizio Garozzo; Dita Maixnerová; Vladimir Tesar; Frank Eitner; Thomas Rauen; Jürgen Floege; Tibor Kovacs; Judit Nagy; Krzysztof Mucha; Leszek Pączek; Marcin Zaniew; Małgorzata Mizerska-Wasiak; Maria Roszkowska-Blaim; Krzysztof Pawlaczyk; Daniel Gale; Jonathan Barratt; Lise Thibaudin; Francois Berthoux; Guillaume Canaud; Anne Boland; Marie Metzger; Ulf Panzer; Hitoshi Suzuki; Shin Goto; Ichiei Narita; Yasar Caliskan; Jingyuan Xie; Ping Hou; Nan Chen; Hong Zhang; Robert J Wyatt; Jan Novak; Bruce A Julian; John Feehally; Benedicte Stengel; Daniele Cusi; Richard P Lifton; Ali G Gharavi
Journal:  Nat Genet       Date:  2014-10-12       Impact factor: 38.330
  9 in total
  1 in total

1.  Lipidomics reveals association of circulating lipids with body mass index and outcomes in IgA nephropathy patients.

Authors:  Yueyi Deng; Qingqing Wu; Wanjia Chen; Li Zhu; Wangyi Liu; Fangying Xia; Liang Sun; Xu Lin; Rong Zeng
Journal:  J Mol Cell Biol       Date:  2021-07-17       Impact factor: 6.216
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.